Quality assurance of drugs used in clinical trials: proposal for adapting guidelines

Paul Newton and colleagues propose that clinical trial guidelines should include a requirement to assess and state the quality of the drugs and other medical products used

Detalles Bibliográficos
Autores principales: Newton, Paul N, Schellenberg, David, Ashley, Elizabeth A, Ravinetto, Raffaella, Green, Michael D, ter Kuile, Feiko O, Tabernero, Patricia, White, Nicholas J, Guerin, Philippe J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2015
Materias:
Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705347/
https://www.ncbi.nlm.nih.gov/pubmed/25716700
http://dx.doi.org/10.1136/bmj.h602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705347/
https://www.ncbi.nlm.nih.gov/pubmed/25716700
http://dx.doi.org/10.1136/bmj.h602

Ejemplares similares